Phase 3 trial: survodutide produced up to 16.6% weight loss in 76 weeks. How it compares to Mounjaro, Wegovy, and Wegovy 7.2 mg.

A new MRI study of 615 adults found higher ultra-processed food intake was linked to more fat stored inside muscle tissue, even when calories were matched.

A Nature study of 27,885 people identified gene variants that predict GLP-1 weight loss and nausea risk, including one specific to Mounjaro users.

The FDA has approved Foundayo (orforglipron), a daily GLP-1 pill for weight loss with no fasting requirements. Average weight loss of 11.2% at 72 weeks.

The OASIS 4 trial found oral semaglutide 25 mg produced 13.6% weight loss over 64 weeks, comparable to injectable Wegovy. UK approval expected late 2026.

Mayo Clinic research found 4 obesity phenotypes that drive weight gain differently. When treatment matched a person's phenotype, weight loss nearly doubled.

A study of 8,000 patients found weight regain after stopping GLP-1 medications was far less than clinical trials predicted. Here's why.

How much does Ozempic cost? Where can you buy it? Should you be on Ozempic? Find out all the information you need on Ozempic before purchasing.

Microdosing Ozempic isn't clinically recommended in the UK. Ozempic is only approved people living with type 2 diabetes and can't be used for weight loss.

The NHS has published research showing the effectiveness of their new digital weight management service where Second Nature is one of 6 providers.